High-Efficiency Assay Promises Rapid Validation of ECHS1 Variants
A team of researchers in Tokyo, Japan, has developed a rapid, efficient assay system for validating ECHS1 variants.
Read MorePosted by Chris Wolski | May 23, 2023 | Molecular Diagnostics |
A team of researchers in Tokyo, Japan, has developed a rapid, efficient assay system for validating ECHS1 variants.
Read MorePosted by Melanie Hamilton-Basich | May 22, 2023 | Kidney Disease |
Screening all adults in the United States for CKD starting at age 35 could be cost effective for the quality of life-years gained.
Read MorePosted by Melanie Hamilton-Basich | May 22, 2023 | Molecular Diagnostics |
With AlphaID At Home, people can self-collect a small saliva sample to learn their risk of developing disease linked to alpha-1.
Read MorePosted by Chris Wolski | May 19, 2023 | Miscellaneous |
AMP has published a report to establish recommendations for standardizing germline variants detected by next-generation sequencing (NGS).
Read MorePosted by Chris Wolski | May 18, 2023 | Pancreatic |
An artificial intelligence tool has successfully identified those at the highest risk for pancreatic cancer up to 3 years before diagnosis.
Read More